Dozens of Clinics Market Risky Cell Therapies to Treat Eye Disorders Dozens of Clinics Market Risky Cell Therapies to Treat Eye Disorders
Scores of clinics across the United States directly advertise expensive - but unproven - stem cell therapies to patients with serious eye diseases, often with devastating results, a new study warns.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news
More News: Advertising | Health | Opthalmology | Stem Cell Therapy | Stem Cells | Study | USA Health